pharmaceutical investing Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China
pharmaceutical investing Dova Pharmaceuticals Signs Exclusive Distribution Agreement with Fosun Pharma For Mainland China and Hong Kong
pharmaceutical investing Tetraphase Pharmaceuticals Enters into Exclusive Development and Commercialization Agreement with Everest Medicines
pharmaceutical investing Amarin Announces Commencement of VASCEPA® Clinical Development in Mainland China
medical device investing CVR Medical Enters China, Executes Preliminary LOI To Launch Its CSS Device In World’s Largest Market
Heliostar Metals to Present at the Precious Metals & Critical Minerals Virtual Investor Conference October 14
Precious Metals & Critical Minerals Virtual Investor Conference Agenda Announced for October 13th - 15th
